Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized …
F Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2017 - Wiley Online Library
We previously reported the results of a phase II/III, double‐blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized …
F Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2017 - search.proquest.com
We previously reported the results of a phase II/III, double‐blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized …
ZFC Zhu FengCai, HSY Hu ShangYing, HY Hong Ying… - 2017 - cabidigitallibrary.org
We previously reported the results of a phase II/III, double-blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized …
FC Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2016 - europepmc.org
We previously reported the results of a phase II/III, double‐blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
[PDF][PDF] Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18–25 years: event-triggered analysis of a …
F Zhu, SY Hu, Y Hong, YM Hu, X Zhang, YJ Zhang… - 2016 - cyberleninka.org
We previously reported the results of a phase II/III, double-blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized …
FC Zhu, SY Hu, Y Hong, YM Hu, X Zhang, YJ Zhang… - 2017 - pubmed.ncbi.nlm.nih.gov
We previously reported the results of a phase II/III, double-blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized …
F Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2017 - search.ebscohost.com
We previously reported the results of a phase II/III, double-blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
[HTML][HTML] Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a …
F Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2017 - ncbi.nlm.nih.gov
Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese
women aged 18–25 years: event‐triggered analysis of a randomized controlled trial - PMC …
women aged 18–25 years: event‐triggered analysis of a randomized controlled trial - PMC …
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized …
FC Zhu, SY Hu, Y Hong, YM Hu, X Zhang… - Cancer …, 2016 - europepmc.org
We previously reported the results of a phase II/III, double‐blind, randomized controlled
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …
study in Chinese women (NCT00779766) showing a 94.2%(95% confidence interval: 62.7 …